Karine Bourgeois, PhD

Chief Scientific Officer
Hennigsdorf, Brandenburg, Germany

Disclosure information not submitted.

Presentation(s):

• DPP3 as a Therapeutic Target in CS - Post ACCOST HH Trial

  Thursday, March 5, 2026
  4:25 PM - 4:32 PM CST